Efficacy and Safety of Prolonged Rituximab Treatment in Patients with Systemic Juvenile Idiopathic Arthritis

Efficacy and Safety of Prolonged Rituximab Treatment in Patients with Systemic Juvenile Idiopathic Arthritis

Aim: to assess efficacy and safety of rituximab treatment in children with systemic juvenile idiopathic arthritis under prolonged follow-up. Patients and methods: results of treatment of 60 children (33 girls and 27 boys) with systemic variant of juvenile idiopathic arthritis being followed-up in rh...

Full description

Bibliographic Details
Main Authors: E. I. Alexeeva, S. I. Valieva, S.S. Akulova, T. M. Bzarova, R. V. Denisova, K. B. Isaeva, T. V. Steptsova, E. V. Mitenko, E. G. Chistyakova, A. N. Fetisova, E. L. Semikina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2013-03-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
children
systemic juvenile idiopathic arthritis
treatment
genetically engineered biological drugs
rituximab
b lymphocytes
cd20
Online Access:https://vsp.spr-journal.ru/jour/article/view/352

Internet

https://vsp.spr-journal.ru/jour/article/view/352

Similar Items